QUOTE AND NEWS
newratings.com  Aug 5  Comment 
INDIANAPOLIS (dpa-AFX) - Elanco Animal Health, a subsidiary of Eli Lilly & Co. (LLY), announced the launch of Osurnia, a treatment for canine otitis externa. An estimated one in 5 dogs will experience the discomfort of otitis externa - an...
FierceBiotech  Aug 5  Comment 
A California judge has stepped between two top research institutions fighting over a vast Alzheimer's disease R&D program with ties to Big Pharma, ordering the study's new managers to hand it back for the time being.
FiercePharma  Aug 4  Comment 
Earlier this year, a U.S. judge dealt Eli Lilly a stinging blow after refusing to toss out lawsuits claiming that the company downplayed withdrawal symptoms linked to its blockbuster antidepressant, Cymbalta. Now Lilly is facing the first U.S....
MedPage Today  Aug 3  Comment 
(MedPage Today) -- Patients with advanced disease also saw some improvement in progression-free survival
FierceBiotech  Jul 27  Comment 
Eli Lilly says that it will push ahead to the end on its Phase III study of evacetrapib, a CETP inhibitor that hopes to succeed where other giants have failed.
newratings.com  Jul 27  Comment 
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) announced it has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the Phase 3 trial of the investigational medicine evacetrapib, based on data from an...
Financial Times  Jul 24  Comment 
Credit Suisse’s strong results; Eli Lilly and Lockheed also in the news
Wall Street Journal  Jul 23  Comment 
Drug maker Eli Lilly’s profit fell 18%, but its purchase of an animal-drug business helped squeeze out a quarterly revenue increase, and the company raised its 2015 outlook.




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki